Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis

被引：38
作者：
Li, Qian-yu [1 ]
Chen, Li [1 ]
Hu, Ning [1 ]
Zhao, Hongmian [1 ]
机构：
[1] Henan Univ, Huaihe Hosp, Dept Hematol, Kaifeng 475000, Henan, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2018年 / 103卷
关键词：
FEZF1-AS1; miR-610; Akt3; Multiple myeloma; GASTRIC-CANCER; PROLIFERATION; EXPRESSION; PROGRESSION; MICRORNAS; INVASION;
D O I：
10.1016/j.biopha.2018.04.094
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Increasing evidence showed that long non-coding RNAs (lncRNAs) play critical roles in tumor progression. FEZF1-AS1 is a cancer-associated lncRNA which upregulated and associated with poor prognosis in patients with cancer. However, the roles of FEZF1-AS1 in multiple myeloma (MM) remains unclear. In the present study, our data revealed that FEZF1-AS1 expression was increased both in MM samples and cell lines. Loss of functional assays indicated that FEZF1-AS1 suppression inhibited MM cells proliferation, arrested cell cycle in G0/G1 phase and induced cell apoptosis in vitro. Furthermore, our data indicated that FEZF1-AS1 functioned as a competing endogenous RNA in MM cells that regulated miR-610 expression, which suppressed Akt3. Those data showed that FEZF1-AS1 promoted MM cells proliferation through regulating miR-610/Akt3 axis, suggesting FEZF1-AS1 could be served as a potential target for cancer therapeutics in MM.
引用
收藏
页码：1727 / 1732
页数：6
相关论文
共 50 条
[21]   Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma [J].
Wang, Ya-Dong ;
Sun, Xue-Jun ;
Yin, Jia-Jun ;
Yin, Min ;
Wang, Wei ;
Nie, Zhe-Qun ;
Xu, Jian .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 :134-141
[22]   Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways [J].
Shen, Xianjuan ;
Shen, Pei ;
Yang, Qian ;
Yin, Qingqing ;
Wang, Feng ;
Cong, Hui ;
Wang, Xudong ;
Ju, Shaoqing .
JOURNAL OF CANCER, 2019, 10 (26) :6502-6510
[23]   The long non-coding RNA HOTAIR promotes thyroid cancer cell growth, invasion and migration through the miR-1-CCND2 axis [J].
Di, Wang ;
Li, Qinghuai ;
Shen, Wei ;
Guo, Hao ;
Zhao, Suyuan .
AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (06) :1298-1309
[24]   Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis [J].
Chang, Shi-Min ;
Hu, Wei-Wei .
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (04) :3384-3396
[25]   Long non-coding RNA SNHG3 promotes the development of non-small cell lung cancer via the miR-1343-3p/NFIX pathway [J].
Zhao, Lijun ;
Song, Xue ;
Guo, Yesong ;
Ding, Naixin ;
Wang, Tingting ;
Huang, Lei .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 48 (02)
[26]   Long non-coding RNA ZEB2-AS1 affects cell proliferation and apoptosis via the miR-122-5p/PLK1 axis in acute myeloid leukemia [J].
Guan, Jianmin ;
Liu, Ping ;
Wang, Aixia ;
Wang, Bo .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (04) :1490-1500
[27]   Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis [J].
Liu, Na ;
Feng, Song ;
Li, Huanhuan ;
Chen, Xiaoguang ;
Bai, Songting ;
Liu, Yufeng .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (02) :367-379
[28]   Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis [J].
Qin, Jianhua ;
Zhu, Tingting ;
Wu, Weihua ;
Chen, Huan ;
He, Yi .
ONCOTARGETS AND THERAPY, 2021, 14 :393-402
[29]   Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway [J].
Meng, Xiangpeng ;
Ma, Jia ;
Wang, Baosheng ;
Wu, Xin ;
Liu, Zhen .
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2020, 76 (02) :301-315
[30]   Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer [J].
Ma, Lei ;
Zhou, Yongjian ;
Luo, Xiaojun ;
Gao, Hai ;
Deng, Xubin ;
Jiang, Yingjie .
ONCOTARGET, 2017, 8 (03) :4125-4135
12345